Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Name
Professor John Deanfield
Bio
Professor John Deanfield is a global leader in cardiovascular health and preventative medicine. His work has been pivotal in shifting the focus from treating established disease to preventing its onset.
He has championed the concept of “Investing in your Arteries” based on his work describing the risk and benefit from cumulative exposure to risk factors and their treatment. As the UK government's first-ever Champion for Personalised Prevention, he has played a role in shaping national health strategies, advocating for a more proactive and individualized approach to healthcare. His work in this capacity has influenced policy decisions and helped set the stage for a new era of preventive medicine in the UK. John was made Commander of the Order of the British Empire (CBE) for services to the prevention and treatment of heart disease in 2021.
He founded and directed the National Institute for Cardiovascular Outcomes Research (NICOR) and championed the use of real-world data for both quality improvement and large-scale, clinical trials.
He has a number of leadership positions in the UK and internationally. He is Chair of the International Scientific Committee at the new Springer Cardiovascular Disease Prevention Center, Charité Universitätsmedizin Berlin, and helped develop the Our Future Health programme, for which he is a Trustee. He is also a strategic advisor to the pharmaceutical and financial industries and has board positions at several early-stage companies.
A prolific researcher, Professor Deanfield has authored over 550 peer-reviewed publications in prestigious medical journals, including The Lancet and New England Journal of Medicine (h=index=157). He regularly presents at major international conferences.
He has championed the concept of “Investing in your Arteries” based on his work describing the risk and benefit from cumulative exposure to risk factors and their treatment. As the UK government's first-ever Champion for Personalised Prevention, he has played a role in shaping national health strategies, advocating for a more proactive and individualized approach to healthcare. His work in this capacity has influenced policy decisions and helped set the stage for a new era of preventive medicine in the UK. John was made Commander of the Order of the British Empire (CBE) for services to the prevention and treatment of heart disease in 2021.
He founded and directed the National Institute for Cardiovascular Outcomes Research (NICOR) and championed the use of real-world data for both quality improvement and large-scale, clinical trials.
He has a number of leadership positions in the UK and internationally. He is Chair of the International Scientific Committee at the new Springer Cardiovascular Disease Prevention Center, Charité Universitätsmedizin Berlin, and helped develop the Our Future Health programme, for which he is a Trustee. He is also a strategic advisor to the pharmaceutical and financial industries and has board positions at several early-stage companies.
A prolific researcher, Professor Deanfield has authored over 550 peer-reviewed publications in prestigious medical journals, including The Lancet and New England Journal of Medicine (h=index=157). He regularly presents at major international conferences.
